Symptoms and Complaints Over-all follow-up visits for 2 week period [clinicaltrials_resource:c3a0a2457a4aef347b4e57cb92770582]
1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Symptoms and Complaints Over-all follow-up visits for 2 week period [clinicaltrials_resource:c3a0a2457a4aef347b4e57cb92770582]
1-100 Scale for each eye. Zero represented the least favorable rating and 100 represented the most favorable.
Bio2RDF identifier
c3a0a2457a4aef347b4e57cb92770582
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c3a0a2457a4aef347b4e57cb92770582
measure [clinicaltrials_vocabulary:measure]
Symptoms and Complaints
time frame [clinicaltrials_vocabulary:time-frame]
Over-all follow-up visits for 2 week period
description
1-100 Scale for each eye. Zero ...... epresented the most favorable.
identifier
clinicaltrials_resource:c3a0a2457a4aef347b4e57cb92770582
title
Symptoms and Complaints Over-all follow-up visits for 2 week period
@en
type
label
Symptoms and Complaints Over-a ...... 0a2457a4aef347b4e57cb92770582]
@en